Tessa Cacciottolo
@tesscacciottolo.bsky.social
Clinician Scientist interested in causes of steatotic liver disease and obesity. Hepatologist. Chain Florey TTI Fellow @mrc-lms.bsky.social
Reposted by Tessa Cacciottolo
#4
With thanks to our collaborators and funders @cambridgebrc.bsky.social @wellcometrust.bsky.social @tesscacciottolo.bsky.social
With thanks to our collaborators and funders @cambridgebrc.bsky.social @wellcometrust.bsky.social @tesscacciottolo.bsky.social
September 3, 2025 at 10:00 AM
#4
With thanks to our collaborators and funders @cambridgebrc.bsky.social @wellcometrust.bsky.social @tesscacciottolo.bsky.social
With thanks to our collaborators and funders @cambridgebrc.bsky.social @wellcometrust.bsky.social @tesscacciottolo.bsky.social
Low cysteine, low GSH, upregulation of the hepatic ISR and OSR with weight loss are reminescent of early liver failure. Intriguing that the proposed application of the science is in obesity management, and begs the question of whether the translational statement has enhanced the paper in this case.
May 24, 2025 at 5:02 PM
Low cysteine, low GSH, upregulation of the hepatic ISR and OSR with weight loss are reminescent of early liver failure. Intriguing that the proposed application of the science is in obesity management, and begs the question of whether the translational statement has enhanced the paper in this case.
Congrats Matt and colleagues! Great story.
April 5, 2025 at 4:27 PM
Congrats Matt and colleagues! Great story.
Very exciting announcement and bodes well for A1ATD and other genetic disorders affecting the liver. #RareDisease
March 11, 2025 at 10:08 AM
Very exciting announcement and bodes well for A1ATD and other genetic disorders affecting the liver. #RareDisease
